Aurélie Morin

1.9k total citations
25 papers, 930 citations indexed

About

Aurélie Morin is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Aurélie Morin has authored 25 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Aurélie Morin's work include Cancer, Hypoxia, and Metabolism (8 papers), Adrenal and Paraganglionic Tumors (7 papers) and Hormonal Regulation and Hypertension (5 papers). Aurélie Morin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Adrenal and Paraganglionic Tumors (7 papers) and Hormonal Regulation and Hypertension (5 papers). Aurélie Morin collaborates with scholars based in France, United Kingdom and United States. Aurélie Morin's co-authors include Judith Favier, Anne‐Paule Gimenez‐Roqueplo, Éric Letouzé, Luis-Jaime Castro-Vega, Charlotte Lussey‐Lepoutre, Florence Cabon, Chris Ottolenghi, Jacques R.R. Mathieu, Alexandre Buffet and Cosimo Martinelli and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Aurélie Morin

25 papers receiving 919 citations

Peers

Countries citing papers authored by Aurélie Morin

Since Specialization

Citations

This map shows the geographic impact of Aurélie Morin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Morin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Morin more than expected).

Fields of papers citing papers by Aurélie Morin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Morin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Morin. The network helps show where Aurélie Morin may publish in the future.

Co-authorship network of co-authors of Aurélie Morin

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Morin. A scholar is included among the top collaborators of Aurélie Morin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Morin. Aurélie Morin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas 2024 ·eLife ·Anne Fajac, Iva Simeonova, Julia Leemput, Marc Gabriel, Aurélie Morin, (unknown), Annaïg Hamon, (unknown), (unknown), (unknown), Marina Pinskaya, Antonin Morillon, Jean‐Christophe Bourdon, Boris Bardot, Franck Toledo	3
2	Persistent Properties of a Subpopulation of Cancer Cells Overexpressing the Hedgehog Receptor Patched 2022 ·Pharmaceutics ·(unknown), (unknown), Aurélie Morin, Chloé Prunier, Virginie Magnone, Kévin Lebrigand, (unknown), (unknown), Judith Favier, Claude Pasquier, Isabelle Mus‐Veteau	2
3	Loss of SDHB Promotes Dysregulated Iron Homeostasis, Oxidative Stress, and Sensitivity to Ascorbate 2021 ·Cancer Research ·(unknown), Sophie Moog, Aurélie Morin, Géraldine Gentric, Sebastian Müller, Alexander P. Morrell, Katarína Kľučková, (unknown), Cynthia L. Andoniadou, Charlotte Lussey‐Lepoutre, Paule Bénit, Alpesh Thakker, Lisa A. Vettore, Jennie Roberts, Raphaël Rodriguez, Fatima Mechta‐Grigoriou, Anne‐Paule Gimenez‐Roqueplo, Éric Letouzé, Daniel A. Tennant, Judith Favier	40
4	TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition 2020 ·Cell Reports ·Aurélie Morin, (unknown), Sophie Moog, Luis-Jaime Castro-Vega, Sylvie Job, Alexandre Buffet, (unknown), (unknown), Anne‐Paule Gimenez‐Roqueplo, Éric Letouzé, Judith Favier	66
5	Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas 2018 ·Cancer Research ·Alexandre Buffet, Aurélie Morin, Luis-Jaime Castro-Vega, Florence Habarou, Charlotte Lussey‐Lepoutre, Éric Letouzé, Hervé Lefèbvre, Isabelle Guilhem, Magalie Haissaguerre, I. Raingeard, (unknown), (unknown), (unknown), Jérôme Bertherat, Laurence Amar, Chris Ottolenghi, Nelly Burnichon, Anne‐Paule Gimenez‐Roqueplo, Judith Favier	99
6	Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis 2018 ·Cell and Tissue Research ·Charlotte Lussey‐Lepoutre, Alexandre Buffet, Aurélie Morin, (unknown), Judith Favier	14
7	Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma 2017 ·Oncotarget ·Aurélie Morin, Carmen Ruggiero, Estelle Robidel, Mabrouka Doghman, Atze T. Das, Rémy Castellano, Emmanuelle Josselin, Judith Favier, Enzo Lalli	8
8	Dosage-dependent regulation of VAV2 expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasion 2017 ·Science Signaling ·Carmen Ruggiero, Mabrouka Doghman, Silviu Sbiera, Iuliu Sbiera, Maddy Parsons, Bruno Ragazzon, Aurélie Morin, Estelle Robidel, Judith Favier, Jérôme Bertherat, Martin Faßnacht, Enzo Lalli	30
9	From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma 2015 ·Molecular and Cellular Endocrinology ·Charlotte Lussey‐Lepoutre, Constance Thibault, Alexandre Buffet, Aurélie Morin, Cécile Badoual, Paule Bénit, Pierre Rustin, Chris Ottolenghi, Maxime Janin, Luis-Jaime Castro-Vega, Jan Trapman, Anne‐Paule Gimenez‐Roqueplo, Judith Favier	31
10	Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism 2015 ·Nature Communications ·Charlotte Lussey‐Lepoutre, Kate E.R. Hollinshead, Christian Ludwig, Mélanie Menara, Aurélie Morin, Luis-Jaime Castro-Vega, Seth J. Parker, Maxime Janin, Cosimo Martinelli, Chris Ottolenghi, Christian M. Metallo, Anne‐Paule Gimenez‐Roqueplo, Judith Favier, Daniel A. Tennant	171
11	Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival 2013 ·Oncogene ·Ming Fang, Iva Simeonova, Boris Bardot, (unknown), Sara Jaber, (unknown), Aurélie Morin, Franck Toledo	11
12	Of mice and men 2013 ·Transcription ·Aurélie Morin, Boris Bardot, Iva Simeonova, (unknown), (unknown), Franck Toledo	1
13	Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors 2012 ·PLoS ONE ·Charlotte Guyader, Jocelyn Céraline, Eléonore Gravier, Aurélie Morin, (unknown), Éva Erdmann, Gonzague de Pinieux, Florence Cabon, Jean‐Pierre Bergerat, Marie‐France Poupon, Stéphane Oudard	15
14	Fuzzy Tandem Repeats Containing p53 Response Elements May Define Species-Specific p53 Target Genes 2012 ·PLoS Genetics ·Iva Simeonova, (unknown), Boris Bardot, (unknown), Aurélie Morin, Ming Fang, (unknown), Franck Toledo	20
15	Thrombospondin-1 Triggers Cell Migration and Development of Advanced Prostate Tumors 2011 ·Cancer Research ·Virginie Firlej, Jacques R.R. Mathieu, Cristèle Gilbert, Loïc Lemonnier, (unknown), Catherine Gallou‐Kabani, Basma Guarmit, Aurélie Morin, Natalia Prevarskaya, Nicolas Barry Delongchamps, Florence Cabon	81
16	Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence 2011 ·The FASEB Journal ·Aurélie Morin, Lauriane Fritsch, Jacques R.R. Mathieu, Cristèle Gilbert, Basma Guarmit, Virginie Firlej, Catherine Gallou‐Kabani, Annick Vieillefond, Nicolas Barry Delongchamps, Florence Cabon	18
17	Systemic Delivery and Quantification of Unformulated Interfering RNAs In Vivo 2009 ·Current Topics in Medicinal Chemistry ·Aurélie Morin, Catherine Gallou‐Kabani, Jacques R.R. Mathieu, Florence Cabon	15
18	SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas 2007 ·PLoS ONE ·Daniel Compagno, Carole Merle, Aurélie Morin, Cristèle Gilbert, Jacques R.R. Mathieu, (unknown), Claire Mauduit, Mohamed Benahmed, Florence Cabon	48
19	Testosterone regulates FGF‐2 expression during testis maturation by an IRES‐dependent translational mechanism 2006 ·The FASEB Journal ·Irma Gabriela González-Herrera, Leonel Prado-Lourenço, Frédéric Pileur, Caroline Conte, Aurélie Morin, Florence Cabon, Hervé Prats, Stéphan Vagner, Françis Bayard, Sylvie Audigier, Anne‐Catherine Prats	42
20	Production of biologically active anti-peptide antibodies in human volunteers immunized with a synthetic peptide of type 24 M protein 1985 ·International Journal of Immunopharmacology ·L Chedid, Michel Jolivet, Aurélie Morin, François Parant, F. Audibert, F Oberling, B. Duclos, E H Beachey, (unknown), Aurélien Tartar	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact